Share Price and 1 Year Extreme Prices Analysis
The share of Cara Therapeutics Inc. (CARA) currently has a value of $15.43 while the company’s 52 week low is at $4.75, the shares dropped to the 52 week low on 07/20/16. While the company’s share hit the 52 week high on 06/27/17 stationing the value of $28.50.
The difference of 52 week low value as well as 52 week high value and the current price of the stock suggests the next move of the shares. If the share price is currently hovering near the 52 week low and the value is achieved in the current past then it can suggest that the price of the shares is likely to go up.
Share Volume Analysis
The volume of the particular stock is the shares bought and sold in a single trading day. The average volume of a stock suggests the liquidity of a particular company. If the average volume is low then the liquidity is low which means it is hard to buy or sell the stock as there are fewer buyers or sellers of the stock.
Currently the shares of Cara Therapeutics Inc. (CARA) has the trading volume of 3.4 Million shares with the average trading volume of 5210 shares.
Price to Earnings Ratio
P/E of the company is not reported.
Earnings per Share EPS
Yet another important factor while evaluating a good buy/sell decision for Cara Therapeutics Inc. (CARA) is its Earnings per Share or EPS. EPS breaks down the profitability of the company on a single share basis.
Currently, EPS of Cara Therapeutics Inc. (CARA) is -0.81 while the analysts predicted the EPS of the stock to be -0.74 suggesting the company fell short of the analysts’ expectations.
Market Capitalization Analysis
Market Capitalization can be thought of as the overall price to buy the company. Market Capitalization if basically the market value of the company’s shares outstanding. Market Cap is also the figure use to determine company’s size, as opposed to using sales or total asset figures.
Cara Therapeutics Inc. (CARA) has a market capitalization of 501.59 Million which suggests the company is a huge company further suggesting that the shares of Cara Therapeutics Inc. (CARA) are stable and safe compared to the lower market capitalization companies.